Skip to main content
Jonathan Trent II, MD, Oncology, Miami, FL

Jonathan C. Trent II MD PhD

Sarcoma


Associate Director, Clinical Research; Director, Sarcoma Program

Join to view full profile
  • 1475 NW 12th AveFl 1Miami, FL 33136

  • Phone+1 305-243-2581

  • Fax+1 305-243-1293

Dr. Trent is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Texas Health Science Center at Houston/M D Anderson Cancer Center
    University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 1999 - 2002
  • University of Texas Health Science Center at Houston
    University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1995 - 1998
  • McGovern Medical School at UTHealth
    McGovern Medical School at UTHealthClass of 1995

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2011 - 2028
  • GA State Medical License
    GA State Medical License 2026 - 2028
  • TN State Medical License
    TN State Medical License 2026 - 2028
  • MS State Medical License
    MS State Medical License 2026 - 2027
  • AL State Medical License
    AL State Medical License 2026 - 2026
  • TX State Medical License
    TX State Medical License 1997 - 2026
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology
  • Internal Medicine
    National Board of Physicians and Surgeons Internal Medicine
  • Medical Oncology
    National Board of Physicians and Surgeons Medical Oncology
  • Medical Oncology
    The National Board of Physicians and SurgeonsMedical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014, 2016-2017
  • CMS Meaningful Use Stage 2 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2013-2014, 2016-2017

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • The Sarcoma Perspective in Gynecologic Oncology 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019
  • Neoadjuvant/Adjuvant Chemotherapy Should Be Considered Standard in High-Risk Extremity Soft Tissue Sarcoma 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018

Press Mentions

  • May 2025 Sylvester Cancer Insights: Essential Tips and Updates
    May 2025 Sylvester Cancer Insights: Essential Tips and UpdatesMay 19th, 2025
  • Sylvester Cancer Tip Sheet - May 2025
    Sylvester Cancer Tip Sheet - May 2025May 17th, 2025
  • ASCO 2025 Tip Sheet from Sylvester Comprehensive Cancer Center
    ASCO 2025 Tip Sheet from Sylvester Comprehensive Cancer CenterMay 1st, 2025

Grant Support

  • North American Star ConsortiumUNIVERSITY HEALTH NETWORK2026–2027
  • Chaperonin (Sulfolobus Shibatae)National Center For Research Resources2006–2009
  • Activity &Resistance Of Gleevec In GI Stromal TumorsNational Cancer Institute2004–2008
  • Mechanism/Activity/Resistance/Gleevec/Gi Stromal Tumors (K23M)National Cancer Institute2005–2006
  • Chaperonins As Self-Assembling Building Blocks For NanotechnologyNational Center For Research Resources2005

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: